Skip to main content

Contemporary Issues in Breast Pathology



Original release date:
June 15, 2022
Access to this course expires on:  April 27, 2025 at 11:59 PM Pacific Time
CME 18.25

Course Description
This course will provide a comprehensive review and update of the pathologic diagnosis and clinical significance of benign, in situ and malignant lesions of the breast identified in surgical specimens and core needle biopsies. The most current adjunctive immunohistochemical and molecular studies to assist in the diagnosis and classification of benign and malignant breast lesions and to guide patient management will be emphasized. The course format will feature a combination of lectures, interactive microscopy sessions, and a digital slide review.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:
  • Describe the diagnostic criteria and clinical significance of a variety of benign, in situ and malignant breast lesions encountered in surgical specimens and core needle biopsies
  • Discuss differential diagnostic problems in breast pathology and the uses and limitations of ancillary immunohistochemical and molecular tests in arriving at the correct diagnosis
  • Discuss prognostic and predictive assays in patients with breast cancer

Continuing Medical Education
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 18.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any financial relationship(s) that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and mitigated all identified conflicts of interest, as applicable.

The following faculty and IM Coordinator reported no relevant financial relationships: Stuart Schnitt, MD, Laura Collins, MD, Edi Brogi, MD, PhD, Ashley Cimino-Matthews, MD, Kimberly Allison, MD, Hannah Wen, MD, PhD

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME credit, all learners must complete the evaluation. View and print your certificate by clicking here.

Buy the Course and get a great discount! Not A Member? Click Here